1-4 of 4
Jessica Hemminger, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers

Andrew M Evens, DO,MSc, Monika Pilichowska, MD PhD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Hong Chang, PhD, Jennifer A. Kanakry, MD, Laurie H Sehn, Tatyana A Feldman, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Jeremy S. Abramson, MD, Athena Kritharis, MD, Oliver W. Press, MD PhD, Timothy S. Fenske, MD, Jonathan W. Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, MDMPH, Bruce Woda, MD, Randy D. Gascoyne, MD, Elaine S. Jaffe, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 375.
https://doi.org/10.1182/blood.V130.Suppl_1.375.375
Published: 2017
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study

Andrew M Evens, DO, MSc, FACP, Monika Pilichowska, MD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, MD, Jeremy S. Abramson, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Oliver W Press, MD PhD, Timothy S. Fenske, MD, Jonathan Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, Gaurav Gupta, MD PhD, Randy D Gascoyne, MD, Elaine Jaffe, MD
Journal: Blood
Blood (2016) 128 (22): 4145.
https://doi.org/10.1182/blood.V128.22.4145.4145
Published: 2016
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome

Athena Kritharis, MD, Jennifer A. Kanakry, Laurie H. Sehn, MDMPH, Tatyana Feldman, MD, Aimee Kroll, MS, Randy D. Gascoyne, MD, Adam M. Petrich, MD, Jeremy S. Abramson, MD, Francisco Hernandez-Ilizaliturri, MD, Zeina Al-Mansour, MD, Camille Adeimy, MD, Jessica Hemminger, MD, Nancy L. Bartlett, MD, Anthony R. Mato, MD, Paolo Caimi, MD, Ranjana Advani, MD, Andreas K. Klein, MD, Izidore S Lossos, MD, Oliver W. Press, MD PhD, Sonali M. Smith, MD, Jesus C Fabregas, MD, Chadi Nabhan, MD FACP, Timothy S. Fenske, MD, Jonathan W. Friedberg, MD, Julie M. Vose, MD MBA, Kristie A. Blum, MD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2014) 124 (21): 1703.
https://doi.org/10.1182/blood.V124.21.1703.1703
Published: 2014
Journal Articles

Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era

Andrew M Evens, DO, MSc, Jennifer A. Kanakry, Laurie H. Sehn, MD, Tatyana Feldman, MD, Aimee Kroll, MS, Randy D. Gascoyne, MD, Adam M. Petrich, MD, Jeremy S. Abramson, MD, Francisco J. Hernandez-Ilizaliturri, MD, Zeina Al-Mansour, MD, Camille Adeimy, MD, Jessica Hemminger, MD, Nancy L. Bartlett, MD, Anthony Mato, Paolo F. Caimi, MD, Ranjana H. Advani, MD, Andreas K. Klein, MD, Izidore S Lossos, MD, Oliver W. Press, MD, PhD, Jonathan W. Friedberg, MD, Julie M Vose, MD, MBA, Kristie A. Blum, MD
Journal: Blood
Blood (2013) 122 (21): 847.
https://doi.org/10.1182/blood.V122.21.847.847
Published: 2013